1. Karolinska Development3Q 2012 Conference Call – November 22, 2012Torbjörn Bjerke, CEO 2. Today’s PresentationThird Quarter HighlightsSelected Portfolio CompaniesFinancial…

1. DISEASES Vivek Kumar st. vincent Pallotti College of Engineering 2. CANCERWATER-BORNE DISEASESINFECTIOUS DISEASES 3. CONTENTS INTRODUCTION ABOUT DISEASES.INTRODUCTION…

1. Corporate Overview Dr Robert Scoffin CEO http;//www.re-pharm.com [email protected] 2. © 2014 Re-Pharm Ltd > Focus on commercially valuable early stage assets. >…

1. Corporate Overview Dr Robert Scoffin CEO http;//www.re-pharm.com/ STAND NUMBER: 27 [email protected] 2. © 2014 Re-Pharm Ltd > Focus on commercially valuable early stage…

1.   2. Quality Performance Service QPS is a GLP-compliant CRO that supports Discovery, Preclinical, and Clinical Development Services: Bioanalysis DMPK Biomarker…

1. GENERAL TOXICOLOGY REPRODUCTIVE TOXICOLOGY GENETIC TOXICOLOGYBIOCOMPATIBILITY TESTINGCLINICAL PATHOLOGYHISTOPATHOLOGYTOXICOLOGY OVERVIEW DMPK Toxicology and Preclinical…

1. TROPICAL MEDICINETROPICAL MEDICINE DEPARTEMENTDEPARTEMENT Medical Education ProgramsMedical Education Programs ‫الرحيم‬ ‫الرحمن‬ ‫ال‬ ‫بسم‬…

1. Paul K. Wotton, Ph.D. President and Chief Executive Officer July 2011 AMEX: AIS 2. 2 This presentation may contain forward-looking statements which are made pursuant to…

1. Paul K. Wotton, Ph.D. President and Chief Executive Officer September 2011 AMEX: AIS 2. 2 This presentation may contain forward-looking statements which are made pursuant…

Produced by: Korean Biologics Pipelines 2015 Series eBook of 4th Biologics World Korea 2015 As 4th Biologics World Korea 2015 is drawing near, we are glad to compile the…